Foldvari Research Group
Welcome to the Foldvari Research Group
Drug Delivery and Pharmaceutical Nanotechnology Laboratory
Dr. Marianna Foldvari is a Professor of Pharmaceutical Sciences and the Canada Research Chair in Bionanotechnology and Nanomedicine (2007-2014) at the University of Waterloo’s School of Pharmacy. Dr. Foldvari’s expertise is in pharmaceutics, dosage forms, drug delivery system design (dermal, transdermal, transmucosal, ocular, and intranasal), nanotechnology, non-viral delivery methods and vaccine development.
Currently, the Foldvari Group is investigating novel materials, methods, mechanisms and pathways to enable the discovery and invention of needle-free administration of medicines. We are working on developing non-invasive drug delivery technologies and pharmaceutical products based on these technologies.
Our objectives are to:
- Develop novel delivery systems and formulations for drugs, proteins, nucleic acids and vaccines
- Create hybrid systems, e.g., DNA-nanoparticles, carbon nanotube composites and other unique structures
- Create nanoprobe systems for diagnostics and repair of biological functions
- Investigate natural and synthetic materials for fabrication of delivery and diagnostic systems
- Create interfacing methods between physical and biological systems
- Investigate molecular functions at the bio/nano interface using computer modelling and visualization of the delivery systems
- Sep. 1, 2020
In September 2020, Antoine Hakim joined as a new PhD Student. He will be investigating novel delivery systems for gene editing applications.
- Sep. 1, 2020
For the Fall 2020 Term Benjamin Guido (Rx2022 Pharmacy Student) joined our group. He is evaluating novel microfluidic culture technologies to study gene delivery into retinal cells under real-time conditions.
- Apr. 9, 2020
First ever webex PhD Thesis defense at UW by Lokesh Narsineni: Development of peptide-modified gemini nanoplexes for gene delivery to the retina.
Congratulations to Lokesh for the excellent defense .